Ocular manifestations of XXXX : a cross-sectional study.

@entity1 @entity227 @entity101 @entity231 @entity63 @entity1539 @entity6810 @entity1596 @entity726 @entity3468 @entity12040 @entity134 @entity941 @entity989 @entity2297
PURPOSE: To detail the spectrum of eye manifestations in @entity12040 and factors predisposing to its development. METHODS: In this cross-sectional study, 61 @entity1 with proven @entity12040 who were identified during a 16-month period were evaluated for disease- and treatment-related eye manifestations. A fundus @entity941 angiography examination was performed where indicated and with the @entity1 consent. RESULTS: The mean (  standard deviation) duration of illness before ophthalmic evaluation was 55    69 months. @entity227 was the most common ocular symptom (30%). Thirty-five @entity1 underwent fundus @entity941 angiography examination. @entity989 was seen in 9 (15%), @entity63 in 4 (7%), and @entity101 retinopathy in 10 (16%) @entity1 . The most common treatment-related ocular complication was @entity134 -induced @entity231 (23%). Other manifestations included @entity1539 (n = 3), @entity6810 (n = 2), @entity134 -induced @entity726 (n = 1), @entity2297 (n = 1), and @entity1596 (n = 1). Those manifesting @entity989 and @entity63 had significantly (P < 0.05) lower blood pressure in both upper limbs compared with @entity1 not manifesting @entity63 . A significant (P < 0.03) proportion of @entity1 with @entity989 and @entity63 had a nonrecordable right upper limb blood pressure. CONCLUSION: Disease- and treatment-related ocular complications are not infrequent in @entity12040 . @entity3468 involving the aortic arch and its branches favors the development of @entity63 .
